Evidence map›Paper›PMID 37096742›Full record

ArticleHuman vaccines & immunotherapeutics2023

COVID-19 vaccine uptake, reasons, and associated factors among older adults in Shenzhen, China.

Pei Xie, XiuYuan Shi, Bin Zhu, Wenjing Zhao, Xiaoheng Li, Xuan Zou, Gang Liu, Xinxin Han

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Pei XieSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
XiuYuan ShiSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
Bin ZhuSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
Wenjing ZhaoSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
Xiaoheng LiShenzhen Center for Disease Prevention and Control, Shenzhen, China.
Xuan ZouShenzhen Center for Disease Prevention and Control, Shenzhen, China.
Gang LiuShenzhen Center for Disease Prevention and Control, Shenzhen, China.
Xinxin HanSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.ORCID 0000-0002-6968-1399
Southern University of Science and Technology · CNShenzhen Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence is limited on the actual uptake of the coronavirus disease 2019 (COVID-19) vaccine among older adults, especially those with chronic diseases, during the pandemic. To examine COVID-19 vaccine uptake, reasons, and associated factor among older adults, a cross-sectional survey was conducted between September 24 and October 20, 2021 among older adults aged 60 and above in Shenzhen, China. Logistic regression analysis was used to examine associations of COVID-19 vaccine uptake with sociodemographic characteristics, pneumonia vaccination history, and participation in health education activities among older adults and among those with chronic diseases. Of the 951 participants, 82.8% reported being vaccinated against COVID-19 during the study period, but this proportion was relatively lower among adults aged 80 and above (62.7%) and those with chronic diseases (77.9%). The top-rated reasons for not being vaccinated included doctors not recommending it due to underlying diseases (34.1%), not being ready for it (18.3%), and failure to make an appointment (9.1%). General older adults who were aged below 70, had a high school and above education, were permanent residents of Shenzhen, were with good health and had pneumonia vaccination history were more likely to take the COVID-19 vaccination. Yet, among older adults with chronic diseases, other than age and permanent residency status, health status was the only significant indicator of COVID-19 vaccine uptake. Our study added to evidence that health condition is the critical barrier to the actual uptake of the COVID-19 vaccine among Chinese older adults, especially those aged 80 and above and those with chronic diseases.

Indexed as

COVID-19COVID-19 VaccinesVaccinationAgedAged, 80 and overAsian PeopleChinaCross-Sectional StudiesHumansCOVID-19 Vaccineschronic diseaseCOVID-19health promotionolder adultsvaccine uptake

Identifiers

PMID37096742
PMCPMC10142320
OpenAlexW4366991638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.